Now Offering KYBELLA™, the First and Only Injectable for Submental Fullness, or Double Chin

VERO BEACH, Fla., July 27, 2015 /PRNewswire/ -- KYBELLA™ (deoxycholic acid) injection, the first and only FDA-approved injectable that contours and improves the appearance of moderate to severe submental fullness, also called "double chin," is now available inVero Beach, Florida. Submental fullness is a common condition that is often resistant to diet and exercise alone and influenced by several factors, including aging, genetics and weight gain.

"We are excited to be the first cosmetic plastic surgery office in Vero Beach to be able to offer KYBELLA™ to patients. Kybella is the first and only FDA approved injectable therapy that targets and removes neck fat without surgery, anesthesia, or external scarring," says Dr.Alan Durkin.

Each in-office treatment with KYBELLA™ is typically 15-20 minutes. When injected into subcutaneous fat, KYBELLA™ causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat. After the aesthetic response is achieved with KYBELLA™, re-treatment is not expected.

With this nonsurgical treatment, many patients experience visible results in two to four treatment sessions spaced at least one month apart. Treatment with KYBELLA™ is customized by Dr. Alan Durkin to the patient's aesthetic goals for an improved chin profile.

Learn more, www.oceandriveplasticsurgery.com or www.mykybella.com.

About Ocean Drive Plastic Surgery™

Ocean Drive Plastic Surgery™ combines style and elegance with a State Certified surgery center, Laser Center, and MedSpa.Concierge-style service along with a complete spectrum of surgical and nonsurgical rejuvenation procedures go hand-in-hand with individualized patient care at Ocean Drive Plastic Surgery™.  Dr. Alan Durkin is certified by the American Board of Plastic Surgery and the American Board of Surgery, is a member of American Society of Plastic Surgeons and American Society for Aesthetic Plastic Surgery. Dr. Durkin is also Vice Chairman of the Department of Surgery at Indian River Medical Center.

About KYBELLA™

KYBELLA™ is the first and only approved injectable drug for contouring moderate to severe submental fullness, also called double chin. KYBELLA™ is a non-human and non-animal formulation of deoxycholic acid, a naturally-occurring molecule in the body that aids in the breakdown and absorption of dietary fat. When injected into subcutaneous fat, KYBELLA™ causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat. 

SOURCE Ocean Drive Plastic Surgery

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.